January 9, 2023 — ReCor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced the appointment of Lara Barghout as President and Chief Executive Officer of ReCor. Barghout will lead the ReCor business strategy and organization in an exciting new direction: the global commercialization of ReCor’s Paradise Ultrasound Renal Denervation (“uRDN”) System for the treatment of hypertension.

January 9, 2023 — When we were little, our parents told us to take our vitamins so we could grow big and strong. Now, researchers from Japan find that one particular supplement may even fix a broken heart.

State-of-the-Art Cardiovascular CT

January 6, 2023 — A study of children and adolescents who received a COVID-19 vaccination following multisystem inflammatory syndrome (MIS-C) found that there were no reports of serious complications including myocarditis or MIS

January 6, 2023 — Patients with congenital heart diseases often suffer from obstructions in the right ventricular outflow tract (RVOT), which carries blood from the heart to the lungs. These obstructions can be repaired with surgical procedures. However, these are temporary fixes that can still result in pulmonary stenosis and/or regurgitation, eventually leading to RVOT dysfunction and even fatal arrhythmias.

International Conference and Expo on Cardiology and Cardiovascular Diseases

January 5, 2023 — Mouaz H. Al-Mallah, MD, MSc, FASNC, director of the cardiovascular PET program at the Houston Methodist DeBakey Heart and Vascular Center, was installed as president of the American Society of Nuclear Cardiology (ASNC) for 2023. Dr. Al-Mallah is also the Beverly B. and Daniel C.

January 5, 2023 — A new study has determined that approximately three percent of all bone scan patients have markers of cardiac amyloidosis, which can lead to heart failure and increased mortality.

Next Generation Cardiovascular Drug Development Summit

Subscribe Now